Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ResMed Inc. Common Stock (NY: RMD )

240.16 -2.42 (-1.00%)
Streaming Delayed Price Updated: 9:56 AM EST, Feb 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 46,356
Open 242.01
Bid (Size) 239.86 (13)
Ask (Size) 240.60 (6)
Prev. Close 242.58
Today's Range 239.76 - 243.41
52wk Range 170.56 - 263.05
Shares Outstanding 146,234,244
Dividend Yield 0.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stock Of The Day: Different Ways To Profit From SoundHound
Shares of SoundHound AI are trading within a range. Some traders will get involved if the stock breaks out or breaks down. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stock Of The Day: Trading The Range In ResMed
If shares of ResMed (RMD) reach support, potential buyers may start to outbid each other. This could force the shares into an uptrend. 
Via Benzinga

Performance

YTD
+5.11%
+5.11%
1 Month
+2.16%
+2.16%
3 Month
-2.23%
-2.23%
6 Month
+13.85%
+13.85%
1 Year
+25.92%
+25.92%

More News

Read More
What You Missed On Friday
Via Talk Markets
Topics Stocks / Equities
What's going on in today's session: S&P500 movers
Via Chartmill
ResMed Earnings Analysis: Q2 Recap
Via Benzinga
What 5 Analyst Ratings Have To Say About ResMed
Via Benzinga
Should you consider RESMED INC (NYSE:RMD) for quality investing?
Via Chartmill
ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Via StockStory
In today's session, there are S&P500 stocks with remarkable trading volume.
Via Chartmill
Top S&P500 movers in Friday's session
Via Chartmill
Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?
Via Benzinga
Topics Stocks
Exposures US Equities
Friday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
ResMed: Digital Health Drives Q2 Growth
Via The Motley Fool
ResMed, In A Buy Zone, Stays Flat After Handily Beating Earnings Views
Via Investor's Business Daily
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
From ResMed Inc.
Via GlobeNewswire
Reasonable Growth, Debt Levels, and a High ROIC Make RESMED INC (NYSE:RMD) Appealing to Quality Investors.
Via Chartmill
Wall Street Remains Flat, Microsoft Eyes Heaviest Drop Since Late 2022, Gold Sets Fresh Records: What's Driving Markets Thursday?
Via Benzinga
This AppLovin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
From ResMed Inc.
Via GlobeNewswire
Earnings Scheduled For January 30, 2025
Via Benzinga
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
Top Stock Reports For UnitedHealth, Costco & IBM
Via Talk Markets
Topics Stocks / Equities
Eli Lilly's Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive?
Via Investor's Business Daily
Exposures Product Safety
This AutoZone Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.